CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
23.84
2.57%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.24
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Core Laboratories NV ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 24.47
Open* 24.27
1-Year Change* 70.08%
Day's Range* 23.84 - 24.35
52 wk Range 13.19-31.42
Average Volume (10 days) 358.37K
Average Volume (3 months) 7.50M
Market Cap 1.05B
P/E Ratio 44.53
Shares Outstanding 46.66M
Revenue 502.79M
EPS 0.51
Dividend (Yield %) 0.1777
Beta 2.67
Next Earnings Date Jul 25, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 29, 2023 23.84 -0.20 -0.83% 24.04 24.45 23.80
Sep 28, 2023 24.47 -0.10 -0.41% 24.57 25.07 24.12
Sep 27, 2023 24.87 0.93 3.88% 23.94 24.87 23.68
Sep 26, 2023 23.33 -0.46 -1.93% 23.79 24.09 23.17
Sep 25, 2023 23.92 -0.06 -0.25% 23.98 24.05 23.37
Sep 22, 2023 24.03 0.22 0.92% 23.81 24.39 23.79
Sep 21, 2023 23.74 -0.56 -2.30% 24.30 24.62 23.57
Sep 20, 2023 24.18 0.78 3.33% 23.40 24.50 23.37
Sep 19, 2023 23.64 -0.69 -2.84% 24.33 24.34 23.25
Sep 18, 2023 24.23 -0.15 -0.62% 24.38 24.72 23.84
Sep 15, 2023 24.78 0.78 3.25% 24.00 25.07 23.93
Sep 14, 2023 24.74 0.39 1.60% 24.35 24.76 24.05
Sep 13, 2023 24.23 -1.34 -5.24% 25.57 25.57 23.82
Sep 12, 2023 25.49 -0.01 -0.04% 25.50 26.37 25.04
Sep 11, 2023 25.29 -0.48 -1.86% 25.77 25.91 25.14
Sep 8, 2023 25.65 -0.39 -1.50% 26.04 26.34 25.54
Sep 7, 2023 26.04 0.69 2.72% 25.35 26.24 25.35
Sep 6, 2023 25.49 1.48 6.16% 24.01 25.54 24.01
Sep 5, 2023 24.33 -0.31 -1.26% 24.64 25.30 24.30
Sep 1, 2023 24.83 0.61 2.52% 24.22 25.45 24.20

Core Laboratories Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 489.735 470.252 487.267 668.21 700.846
Revenue 489.735 470.252 487.267 668.21 700.846
Cost of Revenue, Total 393.655 367.896 374.767 495.579 496.964
Gross Profit 96.08 102.356 112.5 172.631 203.882
Total Operating Expense 448.211 424.99 564.072 571.526 582.224
Selling/General/Admin. Expenses, Total 38.117 44.173 34.033 48.023 62.91
Depreciation / Amortization 17.161 18.516 20.867 22.605 23.087
Interest Expense (Income) - Net Operating 0.229 -0.228 1.16 1.725 2.598
Unusual Expense (Income) 2.264 -1.439 135.268 -1.737 -0.455
Other Operating Expenses, Total -3.215 -3.928 -2.023 5.331 -2.88
Operating Income 41.524 45.262 -76.805 96.684 118.622
Interest Income (Expense), Net Non-Operating -11.57 -9.152 -14.372 -14.69 -13.328
Net Income Before Taxes 29.954 36.11 -91.177 81.994 105.294
Net Income After Taxes 19.658 20.219 -97.073 94.284 79.847
Minority Interest -0.205 -0.492 -0.14 -0.134 -0.263
Net Income Before Extra. Items 19.453 19.727 -97.213 94.15 79.584
Total Extraordinary Items 0 0 -0.424 7.833 -0.058
Net Income 19.453 19.727 -97.637 101.983 79.526
Income Available to Common Excl. Extra. Items 19.453 19.727 -97.213 94.15 79.584
Income Available to Common Incl. Extra. Items 19.453 19.727 -97.637 101.983 79.526
Diluted Net Income 19.453 19.727 -97.637 101.983 79.526
Diluted Weighted Average Shares 46.813 46.69 44.477 44.646 44.474
Diluted EPS Excluding Extraordinary Items 0.41555 0.42251 -2.18569 2.10881 1.78945
Dividends per Share - Common Stock Primary Issue 0.04 0.04 0.28 2.2 2.2
Diluted Normalized EPS 0.44729 0.40525 -0.20885 2.08352 1.78169
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 128.356 127.571 125.966 120.898 115.3
Revenue 128.356 127.571 125.966 120.898 115.3
Cost of Revenue, Total 101.528 99.816 98.93 97.957 96.952
Gross Profit 26.828 27.755 27.036 22.941 18.348
Total Operating Expense 121.875 111.953 111.321 109.246 115.691
Selling/General/Admin. Expenses, Total 16.331 8.724 10.001 6.847 12.545
Depreciation / Amortization 4.044 4.073 4.171 4.36 4.557
Interest Expense (Income) - Net Operating -0.144 0.691 -1.303 1.258 -0.417
Unusual Expense (Income) 1.752 -0.705 -0.096 -0.111 3.175
Other Operating Expenses, Total -1.636 -0.646 -0.382 -1.065 -1.121
Operating Income 6.481 15.618 14.645 11.652 -0.391
Interest Income (Expense), Net Non-Operating -3.429 -3.081 -3.138 -2.707 -2.644
Net Income Before Taxes 3.052 12.537 11.507 8.945 -3.035
Net Income After Taxes 2.442 6.69 7.651 7.156 -1.839
Minority Interest -0.069 0.061 -0.127 -0.09 -0.049
Net Income Before Extra. Items 2.373 6.751 7.524 7.066 -1.888
Total Extraordinary Items 0
Net Income 2.373 6.751 7.524 7.066 -1.888
Income Available to Common Excl. Extra. Items 2.373 6.751 7.524 7.066 -1.888
Income Available to Common Incl. Extra. Items 2.373 6.751 7.524 7.066 -1.888
Diluted Net Income 2.373 6.751 7.524 7.066 -1.888
Diluted Weighted Average Shares 47.481 46.379 47.012 47.143 46.298
Diluted EPS Excluding Extraordinary Items 0.04998 0.14556 0.16004 0.14988 -0.04078
Dividends per Share - Common Stock Primary Issue 0.01 0.01 0.01 0.01 0.01
Diluted Normalized EPS 0.0795 0.13745 0.15869 0.148 0.0038
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 211.702 189.055 165.848 221.237 230.977
Cash and Short Term Investments 15.428 17.703 13.806 11.092 13.116
Cash & Equivalents 15.428 17.703 13.806 11.092 13.116
Total Receivables, Net 115.103 106.741 92.867 138.106 143.15
Accounts Receivable - Trade, Net 106.913 96.83 83.192 131.579 129.157
Total Inventory 60.445 45.443 38.151 50.163 45.664
Prepaid Expenses 15.665 14.059 14.797 15.951 15.351
Other Current Assets, Total 5.061 5.109 6.227 5.925 13.696
Total Assets 578.354 580.853 568.579 774.673 648.827
Property/Plant/Equipment, Total - Net 157.407 172.339 181.678 199.203 122.917
Property/Plant/Equipment, Total - Gross 472.144 478.8 475.656 481.39 400.174
Accumulated Depreciation, Total -314.737 -306.461 -293.978 -282.187 -277.257
Goodwill, Net 99.445 99.445 99.445 213.425 219.412
Intangibles, Net 7.483 8.139 8.583 17.45 13.054
Long Term Investments 3.76
Other Long Term Assets, Total 102.317 111.875 113.025 123.358 58.707
Total Current Liabilities 103.135 90.782 89.75 111.594 102.547
Accounts Payable 45.847 29.726 23.028 35.611 41.155
Accrued Expenses 39.952 39.106 44.519 46.896 30.037
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 17.336 21.95 22.203 29.087 31.355
Total Liabilities 394.096 424.404 497.066 596.808 492.068
Total Long Term Debt 172.386 188.636 259.433 305.283 289.77
Long Term Debt 172.386 188.636 259.433 305.283 289.77
Deferred Income Tax 22.877 24.336 20.585 26.284 7.634
Minority Interest 4.696 4.552 4.06 4.275 4.141
Other Liabilities, Total 91.002 116.098 123.238 149.372 87.976
Total Equity 184.258 156.449 71.513 177.865 156.759
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 1.194 1.188 1.148 1.148 1.148
Additional Paid-In Capital 102.254 101.12 41.184 51.872 57.438
Retained Earnings (Accumulated Deficit) 85.949 68.349 50.456 160.539 156.13
Treasury Stock - Common -1.362 -4.075 -14.075 -29.364 -52.501
Unrealized Gain (Loss) 1.331 -4.538 -1.825 -5.64 -6.243
Other Equity, Total -5.108 -5.595 -5.375 -0.69 0.787
Total Liabilities & Shareholders’ Equity 578.354 580.853 568.579 774.673 648.827
Total Common Shares Outstanding 46.6319 46.3494 44.5728 44.4656 44.3168
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 227.927 211.702 195.215 199.621 202.192
Cash and Short Term Investments 16.285 15.428 13.732 16.148 22.037
Cash & Equivalents 16.285 15.428 13.732 16.148 22.037
Total Receivables, Net 124.48 115.103 109.493 111.499 113.54
Accounts Receivable - Trade, Net 110.699 106.913 100.195 99.18 98.9
Total Inventory 67.342 60.445 54.795 52.551 48.224
Prepaid Expenses 13.197 15.665 11.514 14.252 13.611
Other Current Assets, Total 6.623 5.061 5.681 5.171 4.78
Total Assets 593.617 578.354 570.19 577.54 584.918
Property/Plant/Equipment, Total - Net 159.004 157.407 163.841 167.14 170.094
Goodwill, Net 99.445 99.445 99.445 99.445 99.445
Intangibles, Net 7.268 7.483 7.651 7.837 7.979
Other Long Term Assets, Total 99.973 102.317 104.038 103.497 105.208
Total Current Liabilities 95.624 103.135 87.359 95.909 99.762
Accounts Payable 38.366 45.847 34.343 36.106 34.405
Accrued Expenses 38.247 39.952 37.323 42.291 43.929
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 19.011 17.336 15.693 17.512 21.428
Total Liabilities 398.231 394.096 391.654 408.403 423.133
Total Long Term Debt 180.44 172.386 182.677 186.979 189.807
Long Term Debt 180.44 172.386 182.677 186.979 189.807
Deferred Income Tax 22.268 22.877 22.719 23.322 23.27
Minority Interest 4.765 4.696 4.757 4.63 4.601
Other Liabilities, Total 95.134 91.002 94.142 97.563 105.693
Total Equity 195.386 184.258 178.536 169.137 161.785
Preferred Stock - Non Redeemable, Net 0 0
Common Stock 1.194 1.194 1.188 1.188 1.188
Additional Paid-In Capital 111.235 102.254 106.329 104.779 107.088
Retained Earnings (Accumulated Deficit) 87.855 85.949 79.662 72.601 65.998
Treasury Stock - Common -1.36 -1.362 -4.143 -4.682 -5.736
Unrealized Gain (Loss) 1.541 1.331 1.095 0.846 -1.158
Other Equity, Total -5.079 -5.108 -5.595 -5.595 -5.595
Total Liabilities & Shareholders’ Equity 593.617 578.354 570.19 577.54 584.918
Total Common Shares Outstanding 46.634 46.6319 46.3447 46.3248 46.2837
Property/Plant/Equipment, Total - Gross 417.368 419.765 420.352 418.98
Accumulated Depreciation, Total -315.027 -314.737 -313.1 -309.804
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 19.658 20.219 -97.073 94.284 79.847
Cash From Operating Activities 24.956 36.579 57.868 89.527 111.827
Cash From Operating Activities 17.161 18.516 20.867 22.605 23.087
Deferred Taxes 0.433 6.012 -12.216 -36.345 1.832
Non-Cash Items 12.723 12.395 140.351 16.69 36.052
Cash Taxes Paid 14.078 9.066 21.325 13.804 31.928
Cash Interest Paid 9.3 10.477 11.669 13.631 11.499
Changes in Working Capital -25.019 -20.563 5.939 -7.707 -28.991
Cash From Investing Activities -3.856 -10.223 7.851 -5.677 -70.639
Capital Expenditures -10.216 -13.539 -11.88 -22.269 -22.931
Other Investing Cash Flow Items, Total 6.36 3.316 19.731 16.592 -47.708
Cash From Financing Activities -23.375 -22.459 -63.005 -85.874 -42.472
Financing Cash Flow Items -2.619 -1.369 -1.766 0.008 -1.77
Total Cash Dividends Paid -1.853 -1.834 -12.446 -97.574 -97.251
Issuance (Retirement) of Stock, Net -3.903 51.744 -2.793 -3.308 -7.451
Issuance (Retirement) of Debt, Net -15 -71 -46 15 64
Net Change in Cash -2.275 3.897 2.714 -2.024 -1.284
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 2.442 19.658 12.968 5.317 -1.839
Cash From Operating Activities -3.169 24.956 11.745 5.895 5.29
Cash From Operating Activities 4.044 17.161 13.088 8.917 4.557
Deferred Taxes 0.936 0.433 -1.807 0.53 1.698
Non-Cash Items 9.242 12.723 13.89 10.043 8.529
Cash Taxes Paid 1.541 14.078 10.475 6.966 2.691
Cash Interest Paid 2.956 9.3 7.101 4.359 2.508
Changes in Working Capital -19.833 -25.019 -26.394 -18.912 -7.655
Cash From Investing Activities -2.038 -3.856 -4.914 -2.357 0.428
Capital Expenditures -2.208 -10.216 -8.195 -5.493 -2.297
Other Investing Cash Flow Items, Total 0.17 6.36 3.281 3.136 2.725
Cash From Financing Activities 6.064 -23.375 -10.802 -5.093 -1.384
Financing Cash Flow Items -1.469 -2.619 -2.102 -0.001 -0.001
Total Cash Dividends Paid -0.466 -1.853 -1.389 -0.926 -0.463
Issuance (Retirement) of Stock, Net -0.001 -3.903 -2.311 -2.166 -1.92
Issuance (Retirement) of Debt, Net 8 -15 -5 -2 1
Net Change in Cash 0.857 -2.275 -3.971 -1.555 4.334

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Core Laboratories Company profile

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Core Laboratories N.V. revenues decreased 3% to $470.3M. Net income before extraordinary items totaled $19.7M vs. loss of $97.2M. Revenues reflect Reservoir Description segment decrease of 12% to $313.6M, United States segment decrease of 7% to $148.2M, Other Countries segment decrease of 2% to $322.1M. Net Income reflects Production Enhancement segment income totaling $15.2M vs. loss of $133.4M.

Equity composition

Common Stock EUR.02 Par 3/11, 200M auth., 49,739,912 issd., less 4,164,536 shs. in Treas. @ $261.4M. Insiders own 1.35%. IPO 9/95,2.8M shs @ $12 by Jefferies. PO 11/97, 300.8M. shs(1.4M by Co.) @ $36 by BTAB. 12/97, 2-for-1 stock split. FY'02-03 fincls. & '03 Qs are restated for discont. ops. 07/10, 2-for-1 stock split.

Industry: Oil Related Services and Equipment (NEC)

Van Heuven Goedhartlaan 7 B
1181 LE

Income Statement

  • Annual
  • Quarterly

News

How to Trade The Triple Top

Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

14:13, 27 September 2023
USA flag on the background of stock charts. Financial system in USA

Q4 lookahead: US indices starting to show signs of trouble?

US indices start to draw attention as traders focus on the outlook for Q4.

07:20, 27 September 2023

USD/JPY Climbs Towards Key Highs

USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

11:32, 26 September 2023

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

People also watch

ETH/USD

1,672.82 Price
+0.150% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Oil - Crude

90.04 Price
-1.230% 1D Chg, %
Long position overnight fee 0.0661%
Short position overnight fee -0.0881%
Overnight fee time 21:00 (UTC)
Spread 0.030

XRP/USD

0.52 Price
-3.290% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

BTC/USD

26,970.35 Price
+0.080% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading